KALV · Kalvista Pharmaceuticals, Inc.
SELL 84%
179
Total trades
13
Insiders on record
84%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Apr 17, 2026 | Paul Audhya | SELL | Open-market sale | 54.3K | 0.69 |
| Apr 17, 2026 | Brian Piekos | SELL | Open-market sale | 37.6K | 0.76 |
| Apr 17, 2026 | Nicole Sweeny | SELL | Open-market sale | 37.6K | 0.69 |
| Apr 17, 2026 | Benjamin L Palleiko | SELL | Open-market sale | 193.1K | 0.78 |
| Mar 9, 2026 | Benjamin L Palleiko | SELL | Open-market sale | 107.6K | 0.94 |
| Feb 23, 2026 | Christopher Yea | SELL | Open-market sale | 67.7K | 0.89 |
| Feb 23, 2026 | Brian Piekos | SELL | Open-market sale | 27.5K | 0.96 |
| Feb 23, 2026 | Benjamin L Palleiko | SELL | Open-market sale | 156.2K | 0.94 |
| Feb 23, 2026 | Nicole Sweeny | SELL | Open-market sale | 61.9K | 0.92 |
| Feb 23, 2026 | Paul Audhya | SELL | Open-market sale | 83.3K | 0.90 |
Kalvista Pharmaceuticals, Inc. has 179 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade KALV?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.